symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
FEMY,1.42,0.091128,12611457,22588792,0,0.248-4.75,0.01,Femasys Inc.,USD,0001339005,US31447E1055,31447E105,NASDAQ Capital Market,NASDAQ,Medical Instruments & Supplies,https://www.femasys.com,"Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.",Ms. Kathy  Lee-Sepsick,Healthcare,US,34,770 500 3910,3950 Johns Creek Court,Suwanee,GA,30024,,0,https://financialmodelingprep.com/image-stock/FEMY.png,2021-06-18,False,False,True,False,False
